Skip to main content
See every side of every news story
Published loading...Updated

Lenacapavir to be rolled out via Pepfar to selected countries - Juta MedicalBrief

Summary by Medical Brief
The news that the US Government has made a pre-market commitment to purchase the twice-yearly highly effective injectible drug lenacapavir from Gilead Sciences for the President’s Emergency Plan for Aids Relief (Pepfar) to distribute in eight to 12 high-burden HIV countries in 2026 has been welcomed by experts, including South Africans. Authorities say Pepfar “is seeking to meaningfully reduce the number of new HIV infections, especially in preg…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Brief broke the news in on Wednesday, September 10, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal